Beranda › Iskemia Miokard › New York
Uji klinis Iskemia Miokard di New York
6 studi untuk Iskemia Miokard mencari peserta di lokasi di New York.
Kota di New York
Teks studi resmi (Bahasa Inggris)
Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)
- Northwell Health Lenox Hill Hospital, Manhasset
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07585968A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
- Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York
- Weill Medical College of Cornell University, New York
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07286578Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
- Icahn School of Medicine at Mount Sinai, New York
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06703489The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study
- St. Francis Hospital and Heart Center, Roslyn
Menerima peserta
Usia 35 hingga 85 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06854458AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Mount Sinai Hospital, New York
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Jun 2026 · NCT06699056Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease
- NYU Langone Health, New York
Menerima peserta
Usia 75 hingga 100 · Semua jenis kelamin · Diperbarui 11 Des 2025 · NCT05788666Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.